With its recently launched BCRquest.com data analysis hub, BC Platforms has teamed with the Accelerated Cure Project for MS and Biogen.
A pair of studies has established a potential role for specific gut bacteria in the progression of MS, suggesting therapeutic targeting of the microbiota as a potential treatment.
In PNAS this week: links between the gut microbiome and multiple sclerosis, and more.
The firm's recent funding round will support its CLIA-certified laboratory that opened last year and the launch of its first RNA-based diagnostic test.
In Science this week: a protective gene in C. elegans, and combining EHRs with genetic data to ID HLA-associated variants
Two alleles work together to influence multiple sclerosis risk, a Duke University-led team has found.
Researchers are criticizing a paper linking a rare gene variant to multiple sclerosis, Stat News reports.
A Winthrop-University Hospital team showed that demethylated circulating cell-free DNA from dying oligodendrocytes is a biomarker for relapsing-remitting MS.
Certain bacterial species appear more common in gut microbiomes of individuals with MS, coinciding with inflammation-related gene expression in host blood.
Researchers uncovered four new multiple sclerosis susceptibility loci through a genome-wide association study, and linked them to epigenetic regulation.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.